Home › Cytomegalovirus Infections › California
Cytomegalovirus Infections clinical trials in California
3 studies for Cytomegalovirus Infections are looking for participants at sites in California.
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
- City of Hope Medical Center, Duarte
RecruitingPhase 1/2
Ages 1 to 21 · All sexes · Updated Oct 6, 2025 · NCT03354728Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
- Lucile Packard Children's Hospital, Palo Alto
- Lucile Packard Children's Hospital, Palo Alto
RecruitingPhase 1/2
1 Month – 65 Years · All sexes · Updated Aug 14, 2025 · NCT06909110Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266640From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.